Breast cancer prediction model developed for Hispanic women

Researchers from Kaiser Permanente have developed a new breast cancer model to help clinicians effectively predict the risk in Hispanic patients.

"Hispanics are the largest racial/ethnic minority group in the U.S., so it's important that the National Cancer Institute tool include information from these women in determining their risk score. Our model does that because it is based on data from Hispanic women and specifically tailored for them," said Matthew P. Banegas, PhD, MPH, lead author and researcher from the Kaiser Permanente Center for Health Research.

Based solely on data of Hispanic women, the National Cancer Institute’s Breast Cancer Risk Assessment Tool asks women about risk factors such as first menstrual period, age at the birth of a first child and family history.

"Prior studies have shown that Hispanic women born in the U.S. have a higher breast cancer risk than Hispanic women who emigrate here from other countries," said Banegas. "Our model includes data from U.S. and foreign-born women, so providers will be able to more accurately predict risk based on where the woman was born."

In the development of the model, researchers used data from 1,086 Hispanic women with breast cancer and 1,411 women without. With the inclusion of breast cancer incidence and mortality data from the California Cancer Registry and NCI's Surveillance, Epidemiology and End Results program and data from the Women's Health Initiative and the Four-Corners Breast Cancer Study, the model was shown to accurately predict the number of breast cancer cases.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.

Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. 

The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services.